Your browser doesn't support javascript.
loading
Rationale and Design of the CONCERT-HF Trial (Combination of Mesenchymal and c-kit+ Cardiac Stem Cells As Regenerative Therapy for Heart Failure).
Bolli, Roberto; Hare, Joshua M; March, Keith L; Pepine, Carl J; Willerson, James T; Perin, Emerson C; Yang, Phillip C; Henry, Timothy D; Traverse, Jay H; Mitrani, Raul D; Khan, Aisha; Hernandez-Schulman, Ivonne; Taylor, Doris A; DiFede, Darcy L; Lima, João A C; Chugh, Atul; Loughran, John; Vojvodic, Rachel W; Sayre, Shelly L; Bettencourt, Judy; Cohen, Michelle; Moyé, Lem; Ebert, Ray F; Simari, Robert D.
Afiliación
  • Bolli R; From the Division of Cardiovascular Medicine, University of Louisville, KY (R.B., J.L.).
  • Hare JM; Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, FL (J.M.H., A.K., R.D.M., I.H.-S.).
  • March KL; Division of Cardiovascular Medicine, UFHealth at University of Florida, Gainesville (K.L.M., C.J.P.).
  • Pepine CJ; Division of Cardiovascular Medicine, UFHealth at University of Florida, Gainesville (K.L.M., C.J.P.).
  • Willerson JT; Texas Heart Institute, CHI St. Luke's Health, Houston (J.T.W., E.C.P., D.A.T.).
  • Perin EC; Texas Heart Institute, CHI St. Luke's Health, Houston (J.T.W., E.C.P., D.A.T.).
  • Yang PC; Cardiovascular Medicine, Stanford University School of Medicine, CA (P.C.Y.).
  • Henry TD; Division of Cardiology, Cedars-Sinai Heart Institute, Los Angeles, CA (T.D.H.).
  • Traverse JH; Minneapolis Heart Institute Foundation at Abbott Northwestern Hospital, MN (J.H.T.).
  • Mitrani RD; Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, FL (J.M.H., A.K., R.D.M., I.H.-S.).
  • Khan A; From the Division of Cardiovascular Medicine, University of Louisville, KY (R.B., J.L.).
  • Hernandez-Schulman I; Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, FL (J.M.H., A.K., R.D.M., I.H.-S.).
  • Taylor DA; Texas Heart Institute, CHI St. Luke's Health, Houston (J.T.W., E.C.P., D.A.T.).
  • DiFede DL; Biological Consulting, LLC, Miami, FL (D.L.D.).
  • Lima JAC; Division of Cardiology, Johns Hopkins University, Baltimore, MD (J.A.C.L.).
  • Chugh A; Franciscan Saint Francis Health, Indianapolis, IN (A.C.).
  • Loughran J; From the Division of Cardiovascular Medicine, University of Louisville, KY (R.B., J.L.).
  • Vojvodic RW; Coordinating Center for Clinical Trials, UT Health School of Public Health, Houston, TX (R.W.V., S.L.S., J.B., M.C., L.M.).
  • Sayre SL; Coordinating Center for Clinical Trials, UT Health School of Public Health, Houston, TX (R.W.V., S.L.S., J.B., M.C., L.M.).
  • Bettencourt J; Coordinating Center for Clinical Trials, UT Health School of Public Health, Houston, TX (R.W.V., S.L.S., J.B., M.C., L.M.).
  • Cohen M; Coordinating Center for Clinical Trials, UT Health School of Public Health, Houston, TX (R.W.V., S.L.S., J.B., M.C., L.M.).
  • Moyé L; Coordinating Center for Clinical Trials, UT Health School of Public Health, Houston, TX (R.W.V., S.L.S., J.B., M.C., L.M.) lemmoye@msn.com.
  • Ebert RF; NIH, National Heart, Lung, and Blood Institute, Division of Cardiovascular Sciences, Bethesda, MD (R.F.E.).
Circ Res ; 122(12): 1703-1715, 2018 06 08.
Article en En | MEDLINE | ID: mdl-29703749

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Miocitos Cardíacos / Trasplante de Células Madre / Trasplante de Células Madre Mesenquimatosas / Insuficiencia Cardíaca Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies Límite: Humans Idioma: En Año: 2018 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Miocitos Cardíacos / Trasplante de Células Madre / Trasplante de Células Madre Mesenquimatosas / Insuficiencia Cardíaca Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies Límite: Humans Idioma: En Año: 2018 Tipo del documento: Article